CSS
CGON icon

Cubist Systematic Strategies’s CG Oncology CGON Stock Holding History

Cubist Systematic Strategies’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.73M Buy
+43,067
New +$1.25M 0.01% 1649
2024
Q2 		– Sell
-28,672
Closed -$1.26M – 3099
2024
Q1 		$1.26M Buy
+28,672
New +$1.17M 0.01% 1993

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cubist Systematic Strategies's CGON Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in CG Oncology (CGON) in Q3 2025: 43,067 shares worth $1.73M. The stake represents 0.01% of the portfolio and ranks #1649 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in CGON as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in CGON in Q1 2024 and has held it in 2 quarters since. 176 funds tracked by Wall St. Rank hold CGON as of Q3 2025.

  • Cubist Systematic Strategies held 43,067 shares of CG Oncology worth $1.73M as of Q3 2025.
  • CG Oncology was a new Cubist Systematic Strategies position in Q3 2025.
  • CG Oncology made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1649 holding.
  • Cubist Systematic Strategies first reported a position in CG Oncology in Q1 2024 and has held it in 2 quarters since.
  • 176 funds tracked by Wall St. Rank held CG Oncology as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.